Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Surya Semesta Internusa Tbk. (SSIA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brigit Biofarmaka Teknologi Tbk. vs Surya Semesta Internusa Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume), while Surya Semesta Internusa Tbk. trades at Rp1,695 (market cap 8.23T, 25.63M 24h volume). The key difference: Surya Semesta Internusa Tbk. is far larger — about 49.6× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Surya Semesta Internusa Tbk. is more actively traded (25.63M versus 324K). Which is the better fit depends on your goals.
| OBAT | SSIA | |
|---|---|---|
Market Cap | 166.01B | 8.23T |
Volume | 324K | 25.63M |
Lot | 3.24K | 256.3K |
Turnover | 77.68M | 43.66B |
Average Price | 239.75 | 1,703.42 |
Value | 77.68M | 43.66B |
Indicative Equilibrium Price | 240 | 1,695 |
Indicative Equilibrium Volume | 1 | 2.72K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →About Surya Semesta Internusa Tbk.
PT. Surya Semesta Internusa Tbk (formerly known as PT. Multi Investment Ltd.) was established based on notarial deed No. 37 dated June 15, 1971 of Umi Sutamto, S.H., notary in Jakarta. It is a publicly-listed company engaged in investment in the shares of subsidiaries that develop and manage industrial and real estate, provide construction services, manufacture and market pre-cast and pre-stressed concrete and own hotels.
Read more on SSIA →
